Robert K Hickman

This inventor holds 18 USPTO granted patents and 12 published patent applications and 4 EPO patents, primarily in Antibody Purification. Top assignees: Abbvie Inc., Abbott Laboratories Corporation. Active years: 1999-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert K Hickman. Retrieved from https://idiyas.com/inventor/robert-k-hickman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 12)

% Patents Active = 72.2

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 1.8

ph-index = 9

Forward Citations = 268(Granted Patents)

Location History:

Mundelein, IL (US) (1999 - 2014)
Lexington, SC (US) (2016)
Worcester, MA (US) (2009 - 2022)

Company Filing History:

Abbott Laboratories Corporation

patents

where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...

Areas of Expertise:

Antibody Purification

Anti-IL-13 Antibodies

Protein A Affinity Chromatography

Viral Inactivation

HIV Detection

Rapid Assay

Antigen Constructs

Affinity Chromatography

Artist's Easel

Tool Tray

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12157767 - Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography (2024-12-03),

2. 11390668 - Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography (2022-07-19),

3. 9975948 - Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography (2018-05-22),

4. D751304 - Attachable tool and dust tray for artist's easel (2016-03-15),

5. D750909 - Attachable tool tray for artist's easel (2016-03-08),

6. D750908 - Attachable artist's easel (2016-03-08),

7. 9266950 - Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography (2016-02-23),

8. 9109010 - Viral inactivation during purification of antibodies cross reference to related applications (2015-08-18),

9. 9018361 - Isolation and purification of antibodies using protein a affinity chromatography (2015-04-28),

10. 8895709 - Isolation and purification of antibodies using protein A affinity chromatography (2014-11-25),

11. 8785596 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2014-07-22),

12. 8491904 - Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography (2013-07-23),

13. 7883845 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2011-02-08),

14. 7619061 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2009-11-17),

15. 7615614 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2009-11-10),

Title: Innovations of Robert K. Hickman: A Leader in Antibody Research

Introduction

Robert K. Hickman, based in Worcester, MA, is a prominent inventor with a remarkable portfolio of 18 patents. His innovations primarily focus on the isolation and purification of antibodies, a critical area in pharmaceutical research and development.

Latest Patents

Among his notable patents, the recent innovation, "Isolation and Purification of Anti-IL-13 Antibodies Using Protein A Affinity Chromatography," stands out. This patent discloses advanced methods for isolating and purifying anti-IL-13 antibodies, ensuring a composition that is sufficiently pure for pharmaceutical applications. The techniques described include pH viral reduction/inactivation, ultrafiltration/diafiltration, affinity chromatography, ion exchange chromatography, and hydrophobic chromatography. Additionally, this invention is directed toward pharmaceutical compositions that comprise one or more antibodies developed through these methods.

Career Highlights

Throughout his career, Robert has worked with major companies in the pharmaceutical industry, notably AbbVie Inc. and Abbott Laboratories Corporation. His contributions in these organizations have led to significant advancements in antibody therapy and pharmaceutical development.

Collaborations

Robert has collaborated with esteemed colleagues, including John R. Hackett and Alan M. Golden. Their teamwork has undoubtedly played a vital role in enhancing the innovative processes and research initiatives within the companies they have worked for.

Conclusion

Robert K. Hickman's extensive work in the field of antibody isolation and purification underscores his position as an influential inventor. His patents not only reflect his dedication to advancing pharmaceutical science but also highlight the collaborative spirit within the research community that drives innovation forward.

Profile summary based on public USPTO records.